Biomarkers and assays for carcinogenesis
US6924099B1 · kind B1 · utility
1Cited by
2References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 25, 2000 |
| Grant date | Aug 2, 2005 |
| Priority date | — |
| Expiry date | Jan 25, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/142
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to carcinogenesis biomarkers produced by phenobarbital-treated rat hepatocytes, nucleic acid molecules that encode carcinogenesis biomarkers or a fragment thereof and nucleic acid molecules that are useful as probes or primers for detecting or inducing carcinogenesis, respectively. The invention also relates to applications of the factor or fragment such as forming antibodies capable of binding the carcinogenesis biomarkers or fragments thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.